Editing Inspira Pharmaceuticals
Revision as of 09:49, 5 April 2022 by 94.119.64.2 (talk) (Created page with "==Summary== Inspira Pharma is developing a potential new therapy for COVID-19. The active molecules being tested are plant-based and have shown an ability to destroy the SARS-CoV-2 virus in the lab. Funds raised will be used to test clinical formulations and prove safety and efficacy in humans. * Patent protected plant-based formulations (under license) * Proven to kill SARS-CoV-2 in early stage lab testing * Platform technology - Potential for a range of lung diseases...")
Warning: You are editing an out-of-date revision of this page. If you publish it, any changes made since this revision will be lost.
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Retrieved from ‘https://stockhub.co/research/Inspira_Pharmaceuticals’